Filing Details
- Accession Number:
- 0001179110-20-011949
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-15 18:24:40
- Reporting Period:
- 2020-12-14
- Accepted Time:
- 2020-12-15 18:24:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1280600 | Acceleron Pharma Inc | XLRN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1214938 | F Kevin Mclaughlin | 128 Sidney Street Cambridge MA 02139 | Svp, Cfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-14 | 7,252 | $41.20 | 18,468 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-12-14 | 7,700 | $27.97 | 26,168 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-12-14 | 24,986 | $30.17 | 51,154 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-12-14 | 2,590 | $40.61 | 53,744 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-14 | 42,528 | $130.14 | 11,216 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to Purchase Common Stock | Disposition | 2020-12-14 | 7,252 | $0.00 | 7,252 | $41.20 |
Common Stock | Option to Purchase Common Stock | Disposition | 2020-12-14 | 7,700 | $0.00 | 7,700 | $27.97 |
Common Stock | Option to Purchase Common Stock | Disposition | 2020-12-14 | 24,986 | $0.00 | 24,986 | $30.17 |
Common Stock | Option to Purchase Common Stock | Disposition | 2020-12-14 | 2,590 | $0.00 | 2,590 | $40.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-01-08 | No | 4 | M | Direct | |
0 | 2026-03-03 | No | 4 | M | Direct | |
5,163 | 2027-03-02 | No | 4 | M | Direct | |
26,262 | 2028-03-01 | No | 4 | M | Direct |
Footnotes
- The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The shares of common stock underlying this stock option award vested in equal quarterly installments over the four years after the grant.
- The shares of common stock underlying this stock option award vested in equal quarterly installments over the four years after January 1, 2016.
- The shares of common stock underlying this stock option award vest in equal quarterly installments over the four years after January 1, 2017.
- The shares of common stock underlying this stock option award vest in equal quarterly installments over the four years after January 1, 2018.